vTv Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:VTVT   3:59:51 PM EDT
0.45
-0.02 (-4.48%)
Earnings Announcements

vTv Therapeutics Announces 2022 First Quarter Financial Results

Published: 05/12/2022 11:56 GMT
vTv Therapeutics Inc - Ordinary Shares - Class A (VTVT) - Vtv Therapeutics Announces 2022 First Quarter Financial Results and Provides Corporate Update.
Vtv Therapeutics Inc - Company's Cash Position As of March 31, 2022, Was $12.1 Million Compared to $13.4 Million As of December 31, 2021.
Vtv Therapeutics Inc - Diluted Net Loss per Share Was $0.10 for Three Months Ended March 31, 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $25 Million
Next Quarter EPS Guidance is expected to be $0.05

More details on our Analysts Page.